Cite
APA Citation
Sanchez, L., Richter, J., Cho, H. J., Jagannath, S., Madduri, D., Parekh, S., Richard, S., Tam, L., Verina, D., & Chari, A. (2021). subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma. Therapeutic advances in hematology, 12, . http://access.bl.uk/ark:/81055/vdc_100122732743.0x000015